ArticlePsychological medicine2023
Reading the mind in the eyes and cognitive ability in schizophrenia- and autism spectrum disorders.
Article in Psychological medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 9 citations in OpenAlex.
- Different effects of social cognitive skills training in schizophrenia and autism spectrum disorder: A rater-blinded, multicenter, randomized controlled trial.Psychiatry and clinical neurosciences · 2026Trial
- Cognitive pathways to communicative-pragmatic dysfunction in schizophrenia: The role of autistic symptoms.Schizophrenia research. Cognition · 2026Article
- Reading body and face language in male schizophrenia.Schizophrenia (Heidelberg, Germany) · 2026Article
- Comparative Analysis of Social Cognitive and Neurocognitive Performance Across Autism and Schizophrenia Spectrum Disorders.Schizophrenia bulletin · 2026Article
- Alterations of NoGo P300 ERP in schizophrenia in social setting: a hyperscanning study.Translational psychiatry · 2025Article
- Harmonizing cross-cultural and transdiagnostic assessment of social cognition by expert panel consensus.Schizophrenia (Heidelberg, Germany) · 2025Article
- Inferring social signals from the eyes in male schizophrenia.Schizophrenia (Heidelberg, Germany) · 2024Article
- Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia.Advances in neurobiology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSchizophrenia (SZ) and autism spectrum disorders (ASD) are characterized by difficulties in theory of mind (ToM). We examined group differences in performance on a ToM-related test and associations with an estimated IQ.
methodsParticipants [
resultsSZ (
conclusionsSZ and ASD are characterized by impairments in RMET. IQ contributed significantly to RMET performance and accounted for group differences in RMET between SZ and ASD. This suggests that non-social cognitive ability needs to be included in comparative studies of the two disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.